Immunotherapy in Nonmelanoma Skin Cancer

被引：5
|
作者：
Bassas Freixas, P. [1 ]
Aparicio Espanol, G. [1 ]
Garcia-Patos Briones, V [1 ]
机构：
[1] Hosp Univ Vail dHebron, Serv Dermatol, Barcelona, Spain
来源：
ACTAS DERMO-SIFILIOGRAFICAS | 2019年 / 110卷 / 05期
关键词：
Nonmelanoma skin cancer; Immunotherapy; Programmed cell death protein 1 (PD-1); Programmed death ligand 1 (PD-L1); Cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4); SQUAMOUS-CELL CARCINOMA; LONG-TERM SURVIVAL; DEATH LIGAND; IPILIMUMAB; EXPRESSION; PEMBROLIZUMAB; REGRESSION; BLOCKADE; CTLA-4; PD-L2;
D O I：
10.1016/j.ad.2018.09.013
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Immunotherapy is emerging as a new and promising treatment for a great variety of tumors, including nonmelanoma skin cancer. Checkpoint inhibitors - antibodies that block proteins that regulate the immune system - mainly target the surface protein CTLA-4 (cytotoxic T-lymphocyte-associated antigen 4) and the PD-1/PD-L1 (programmed cell death protein 1/PD-ligand 1) axis. We review the CTLA-4 and PD-1/PD-L1 pathways and current evidence supporting checkpoint inhibitor therapy in the main types of nonmelanoma skin cancer. (C) 2018 AEDV. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码：353 / 359
页数：7
相关论文
共 50 条
  • [21] NONMELANOMA SKIN-CANCER
    VIRE, CG
    FRUMKIN, A
    EVERETT, MA
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 18 (01) : 133 - 137
  • [22] Treatment of Nonmelanoma Skin Cancer
    Guerrero, Cesar E.
    Elewski, Boni E.
    Elmets, Craig A.
    JAMA INTERNAL MEDICINE, 2013, 173 (22) : 2096 - 2097
  • [23] Diagnosis of nonmelanoma skin cancer
    Brodland, DG
    CLINICS IN DERMATOLOGY, 1995, 13 (06) : 551 - 557
  • [24] Epidemiology of nonmelanoma skin cancer
    Strom, SS
    Yamamura, Y
    CLINICS IN PLASTIC SURGERY, 1997, 24 (04) : 627 - +
  • [25] Nonmelanoma skin cancer mortality
    Weinstock, MA
    SKIN CANCER AND UV RADIATION, 1997, : 534 - 539
  • [26] Cryotherapy of nonmelanoma skin cancer
    August, PJ
    CLINICS IN DERMATOLOGY, 1995, 13 (06) : 589 - 592
  • [27] Hydrochlorothiazide and nonmelanoma Skin Cancer
    Geyer, Sara
    Yazdi, Amir S.
    HAUTARZT, 2019, 70 (02): : 148 - 149
  • [28] Nonmelanoma skin cancer.
    Nguyen T.H.
    Ho D.Q.
    Current Treatment Options in Oncology, 2002, 3 (3) : 193 - 203
  • [29] Polyamines and nonmelanoma skin cancer
    Gilmour, Susan K.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) : 249 - 256
  • [30] Genetics of nonmelanoma skin cancer
    Tsao, H
    ARCHIVES OF DERMATOLOGY, 2001, 137 (11) : 1486 - 1492
12345